Andrea Testa
0000-0002-8973-9711
9 papers found
Refreshing results…
The 17th EFMC Short Course on Medicinal Chemistry on Small Molecule Protein Degraders
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type
Translating PROTAC chemical series optimization into functional outcomes underlying BRD7 and BRD9 protein degradation
Inducible Degradation of Target Proteins through a Tractable Affinity-Directed Protein Missile System
Stereoselective synthesis of allele-specific BET inhibitors
Rapid and Reversible Knockdown of Endogenously Tagged Endosomal Proteins via an Optimized HaloPROTAC Degrader
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Preclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters
3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation
Missing publications? Search for publications with a matching author name.